New Data at DDW 2025 Further Demonstrates the TissueCypher Test’s Ability to Identify Patients at Increased Risk for Developing Esophageal Cancer
Additionally, an expert physician panel convened by EndoscopyNow will host a product…
Roche granted FDA Breakthrough Device Designation for first AI-driven companion diagnostic for non-small cell lung cancer
April 29, 2025 01:00 ET | Source: F. Hoffmann-La Roche Ltd The…
GenVivo Highlights GEN-1013: A Novel Delivery of an IL-12 Immunotherapy at the 2025 American Association for Cancer Research (AACR) Annual Meeting
GEN-1013 was studied in an aggressive CT26 murine cancer model using both…
Kham’s House From Grief to Grace: One Mothers Mission to Support Young Cancer Warriors Now Celebrates Three Years of Hope
April 21, 2025 10:00 ET | Source: Kham’s House Dallas, TX, April…
RevitaLash Cosmetics Announces Road to $10 Million Goal in Support of Breast Cancer Initiatives
VENTURA, Calif., April 15, 2025 /PRNewswire/ -- RevitaLash® Cosmetics, globally recognized for…
Arkade Developers Supports 263 Cancer Patients Through Care Per Sq Ft Initiative, Collects 122 Blood Units in Strong Partnership with Tata Memorial Hospital and Sajjan Jain Trust
MUMBAI, India, April 7, 2025 /PRNewswire/ -- Arkade Developers Limited, through its…
NCCN 2025 Annual Conference Illustrates the Critical Impact of Cancer Research on Improving Lives
The National Comprehensive Cancer Network celebrated its 30th anniversary with a series…
FDA approves Novartis radioligand therapy Pluvicto for earlier use before chemotherapy in PSMA-positive metastatic castration-resistant prostate cancer
Ad hoc announcement pursuant to Art. 53 LR New indication approximately triples…
Predictive Oncology Successfully Develops Predictive Models Derived from Never-Before-Seen Compounds for Prevalent Cancer Indications Including Breast, Colon and Ovary
March 25, 2025 07:00 ET | Source: Predictive Oncology Inc. Company successfully…
Oxford BioTherapeutics Enters into a Strategic Collaboration with Roche to Discover Novel Targets for Antibody-Based Therapeutics for the Treatment of Cancer
March 19, 2025 04:00 ET | Source: Oxford BioTherapeutics Collaboration leverages OBT’s…